Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07172893 · ClinicalTrials.gov registry record · Phase 4
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
A Phase 4 study of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU), sponsored by HealthTech Wound Care.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 10
- Study locations
NCT07172893 is a Phase 4 study of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU) that is actively recruiting participants, run by HealthTech Wound Care. The registered enrollment target is 150 participants, below the 507-participant average among 13 other Diabetic Foot Ulcer (DFU) trials with a reported enrollment target (70% lower). The trial reports 10 study locations across 6 states.
The verdict
NCT07172893, a Phase 4 study of Diabetic Foot Ulcer (DFU) and Venous Leg Ulcer (VLU), is actively recruiting participants, sponsored by HealthTech Wound Care.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic non-healing wounds in patients with chronic non-healing ulcers.
Conditions Studied
Interventions
- BIOLOGICAL DermaBind TL
Study Locations (10)
Florida
- Midland Florida Clinical Research Center - DeLand
- Pharmakon Medical Research - Palm Beach Gardens
- Vital Medical Research - Sweetwater
North Carolina
- US Foot and Ankle Specialists-Cary Satellite Site - Cary
- US Foot and Ankle Specialists - Raleigh
Ohio
- US Foot and Ankle Specialists - Blue Ash
- Lower Extremity Institute for Research and Therapy - Boardman
Michigan
- EMbassy Research Network - Bloomfield Township
Texas
- Perfizien Clinical Research, LLC. - Houston
Virginia
- Foot and Ankle Specialists of the Mid-Atlantic - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-12-10 |
| Est. Completion | 2027-05-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07172893
The ClinicalTrials.gov registry entry for NCT07172893 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 507-participant average among 13 other Diabetic Foot Ulcer (DFU) trials with a reported enrollment target (70% lower). The listed sponsor is HealthTech Wound Care, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetic Foot Ulcer (DFU) appearing as the primary indexed condition, and to 1 intervention - of which DermaBind TL is the first listed.
NCT07172893 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Florida, North Carolina, Ohio.
Frequently Asked Questions
What is clinical trial NCT07172893 about?
NCT07172893 is a clinical study titled "A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL". The purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic non-healing wounds in patients with chronic non-healing ulcers.
What is the current status of trial NCT07172893?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2025-12-10. Estimated completion is 2027-05-21.
What conditions does trial NCT07172893 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU).
What interventions are being tested in trial NCT07172893?
The interventions under investigation include: DermaBind TL (BIOLOGICAL).
Who is sponsoring clinical trial NCT07172893?
This trial is sponsored by HealthTech Wound Care, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07172893 being conducted?
This trial has 10 study locations across Florida, Michigan, North Carolina, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer (DFU)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
RECRUITING · Phase 4
-
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
RECRUITING · NA
-
CARE-D-FOOT-Nav Pilot
RECRUITING · NA
-
A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs
RECRUITING · NA
-
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.